An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations.
about
Computationally Modeling Lipid Metabolism and Aging: A Mini-reviewDiabetes: Models, Signals, and Control.Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model.A model-based approach to predict longitudinal HbA1c, using early phase glucose data from type 2 diabetes mellitus patients after anti-diabetic treatment.An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics.An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers.Identification of the mechanism of action of a glucokinase activator from oral glucose tolerance test data in type 2 diabetic patients based on an integrated glucose-insulin model.A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design.Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.Modeling disease progression and rosiglitazone intervention in type 2 diabetic Goto-Kakizaki ratsMechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki ratsPopulation pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitus.Mathematical models of energy homeostasis.Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes.Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes.A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development.Choosing an optimal input for an intravenous glucose tolerance test to aid parameter identification.Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment.Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults.Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetes.Exploring inductive linearization for pharmacokinetic-pharmacodynamic systems of nonlinear ordinary differential equations.The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model.Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetes.The impact of mathematical modeling on the understanding of diabetes and related complications.A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age.An automated sampling importance resampling procedure for estimating parameter uncertainty.Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart.Model-Based Interspecies Scaling of Glucose Homeostasis.Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.Assessment of glycemic response to an oral glucokinase activator in a proof of concept study: application of a semi-mechanistic, integrated glucose-insulin-glucagon model.
P2860
Q28087689-1D615673-0D4D-4640-B301-A581CB19CEC3Q30434551-B1B5E8D0-D889-4582-973D-651AC3EA58D1Q30578482-16510558-197B-4A6E-B463-FFDA84A82063Q30619387-53AD854A-76E3-4CFF-A42E-14CBB4BBF8F9Q31131623-7D04E564-0BB5-4F3A-91E4-315B7F7EA243Q33516679-5D258D41-FD63-4637-9A82-5E1BA3B3D03AQ34102632-21BDE5B5-BFEC-4388-91AD-28BA95FBB37CQ35318135-911D7C43-8E3F-41F3-9B11-8BAD53C86413Q35856775-40537D61-C4BA-4617-BBCD-5361F5F021D6Q35996694-4CF34020-E2D1-4C79-AB74-A1728524CBA2Q37055749-C4529156-36A7-4E18-8473-D41BA317E94DQ37207848-714BC6CF-6071-4882-BF75-488FD8BA0792Q37210699-7A2F5779-6A88-4C2A-95EC-84C7BDA225EAQ37706883-45DC573E-4EA6-45E8-8679-784039BA52CCQ38558336-D19A7140-B9F0-4F5D-BE42-DB6A118189B9Q38707493-57B6323E-FF4D-4338-BF03-11CC375C1476Q38707612-9C6CB87F-2860-483A-AE5A-17D2BCFDD58AQ38838596-09D81C06-7191-42EC-B1FB-9A7135AD72CDQ39100650-632DCB27-CE51-4D6C-B05D-140A01853203Q39538576-A27A584C-58A8-4AB1-9E6A-EEEFF77A9446Q40183322-EB3BCBB8-854A-4504-B5F9-7F5A608FFD45Q40678970-F433BFD3-6F4F-4C31-8510-77BF9103E700Q40680482-FD1FCC35-8F35-4E50-B688-3927FB4EA06FQ41819906-4D769385-D8E1-490A-80BB-4D2A197448C0Q43089518-00F2CC3F-7952-4F25-AB36-3BC0E07B443BQ46078169-AEF7AD12-0A35-4355-BB0C-90D895415051Q46132737-027B73E6-6CA2-43FA-9FD2-56C5A1C0A1B8Q46299047-2AE14410-A42E-475C-B46F-E6D241142FD8Q47342428-A33D8F90-D8CC-404F-8330-6826E8754164Q54463834-754C9280-C07D-4321-AF42-4497909F7141
P2860
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
An integrated model for glucos ...... ravenous glucose provocations.
@en
An integrated model for glucos ...... ravenous glucose provocations.
@nl
type
label
An integrated model for glucos ...... ravenous glucose provocations.
@en
An integrated model for glucos ...... ravenous glucose provocations.
@nl
prefLabel
An integrated model for glucos ...... ravenous glucose provocations.
@en
An integrated model for glucos ...... ravenous glucose provocations.
@nl
P2093
P2860
P921
P356
P1476
An integrated model for glucos ...... ravenous glucose provocations.
@en
P2093
Hanna E Silber
Mats O Karlsson
Nicolas Frey
Petra M Jauslin
Ronald Gieschke
Ulrika S H Simonsson
P2860
P304
P356
10.1177/0091270007304457
P577
2007-09-01T00:00:00Z